Document is current
Any future updates will be listed below
-
Authors
Parajuli, Bishal
Midya, Vishal
Kiddle, Ryan
De Jager, Nicola
Eggers, Shoshannah
Spakowicz, Daniel
Hoyd, Rebecca
Salhia, Bodour
Chan, Carlos H. F.
Churchman, Michelle L.
Rounbehler, Robert J.
Yao, Song
Rutkowski, Melanie R.
Tarhini, Ahmad A.
Mudaranthakam, Dinesh Pal
Masood, Ashiq
Bocklage, Therese J.
Lentz, Robert W.
Hatoum, Hassan
Ilozumba, Mmadili N.
Hardikar, Sheetal
Ulrich, Cornelia M.
Round, June L.
Riedlinger, Gregory
Shriver, Craig D.
Bosch, Dustin E.
-
Funding
Funding for this research was provided by:
American Cancer Society (IRG-21-141-46-IRG)
American Cancer Society (RSG-23-1023205)
National Cancer Institute (R25CA273964)
National Institute on Aging (K01AG070310)
American Lung Association (1046611)
National Institute of Allergy and Infectious Diseases (K08AI159619)
- License Information
-
More Information
Article History
Received: 2 June 2025
Accepted: 10 November 2025
First Online: 24 November 2025
Competing interests
: RWL acknowledges clinical research funding to institution from ALX Oncology, Merck, Lilly, Guardant, EDDC, Boehringer Ingelheim, and AstraZeneca, consulting/advisory role (honoraria to institution) for Agenus, Boehringer Ingelheim, Merck, Natera, and consulting/advisory role (unpaid) for Kahr and EDDC. GR has advisory roles with AstraZeneca, Pfizer, and Bayer in the past 2 years that have ended.
